REQUEST A DEMO
Total
USD $0.00
Search more companies

Wellbe Pharmaceuticals S.A. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: Beverage Manufacturing | Pharmaceutical and Medicine Manufacturing | Other Miscellaneous Manufacturing | Retail Trade | Pipeline Transportation | Rental and Leasing Services | Scientific Research and Development Services | All Other Professional, Scientific, and Technical Services
Full name: Wellbe Pharmaceuticals S.A. Profile Updated: April 12, 2024
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Wellbe Pharmaceuticals S.A. is a company based in Poland, with its head office in Warsaw. The company operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers industry. It was first established on January 26, 2017. Its’ total assets recorded a negative growth of 75.27%.

Headquarters
Ul. Inflancka 4B/Bud.C
Warsaw; Mazowieckie; Postal Code: 00-189

Contact Details: Purchase the Wellbe Pharmaceuticals S.A. report to view the information.

Website: https://5f74bf8685c02.site123.me

Basic Information
Outstanding Shares:
Purchase the Wellbe Pharmaceuticals S.A. report to view the information.
Registered Capital:
Purchase the Wellbe Pharmaceuticals S.A. report to view the information.
Incorporation Date:
January 26, 2017
Key Executives
Company Performance
Financial values in the chart are available after Wellbe Pharmaceuticals S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Total operating revenue
-80.52%
Operating profit (EBIT)
21.06%
EBITDA
15.87%
Net Profit (Loss) for the Period
9.17%
Total assets
-75.27%
Total equity
-12.43%
Return on Equity (ROE)
-1.33%
Debt to Equity Ratio
3.14%
Quick Ratio
-0%
Cash Ratio
-0%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?